Duggan Robert W's Form 4 filing
Pulse Biosciences, Inc. (PLSE) · filed Sep 12, 2025
- Accession no.
- 0001437749-25-028988
- Filed
- Sep 12, 2025
- Trade date
- Sep 11, 2024-Sep 10, 2025
- Filing delay
- 366 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $2.79M. It was filed 366 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Duggan Robert WCIK 0001055919 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2025 | Common Stock | PPurchaseAcquired | +34,659 | $14.66F1 | +$508,100.94 | 47,551,200 | Direct | |
| Sep 11, 2024 | Common Stock | PPurchaseAcquired | +12,800 | $14.77F2 | +$189,056 | 47,564,000 | Direct | |
| Sep 12, 2024 | Common Stock | PPurchaseAcquired | +145,140 | $14.41F3 | +$2,091,467.4 | 47,709,140 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Volume-weighted average price. The price per share actually paid by the Reporting Person ranged from $14.51 to $14.81 per share. For all transactions reported in this Form 4 using a weighted average price, the Reporting Person undertakes upon request by the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price within the range.
Referenced by the price of 1 transaction in Table I.
- F2
Volume-weighted average price. The price per share actually paid by the Reporting Person ranged from $14.57 to $14.79 per share.
Referenced by the price of 1 transaction in Table I.
- F3
Volume-weighted average price. The price per share actually paid by the Reporting Person ranged from $13.90 to $14.75 per share.
Referenced by the price of 1 transaction in Table I.